Details of the Target
General Information of Target
Target Site Mutations in Different Cell Lines
Cell line | Mutation details | Probe for labeling this protein in this cell | |||
---|---|---|---|---|---|
HCT116 | SNV: p.R484W | . | |||
HCT15 | SNV: p.T308A | . | |||
JURKAT | Deletion: p.A253LfsTer20 | Compound 10 Probe Info | |||
KYSE510 | SNV: p.E448Q | . | |||
LNCaP clone FGC | SNV: p.A143S | . | |||
MDAMB453 | SNV: p.S377R | . | |||
MOLT4 | SNV: p.A289D; p.A396V | IA-alkyne Probe Info | |||
NCIH2291 | SNV: p.G456S | . |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
TH211 Probe Info |
![]() |
Y192(7.61); Y394(20.00); Y441(20.00); Y470(20.00) | LDD0260 | [1] | |
DBIA Probe Info |
![]() |
C378(5.19); C465(9.86); C465(24.45) | LDD0209 | [2] | |
4-Iodoacetamidophenylacetylene Probe Info |
![]() |
C378(0.00); C217(0.00); C465(0.00); C224(0.00) | LDD0038 | [3] | |
IA-alkyne Probe Info |
![]() |
C378(0.00); C217(0.00); C465(0.00) | LDD0036 | [3] | |
IPIAA_L Probe Info |
![]() |
C224(0.00); C378(0.00); C217(0.00) | LDD0031 | [4] | |
Lodoacetamide azide Probe Info |
![]() |
C378(0.00); C465(0.00); C217(0.00); C224(0.00) | LDD0037 | [3] | |
KY-26 Probe Info |
![]() |
N.A. | LDD0301 | [5] | |
Compound 10 Probe Info |
![]() |
C217(0.00); C378(0.00); C465(0.00) | LDD2216 | [6] | |
Compound 11 Probe Info |
![]() |
C378(0.00); C465(0.00) | LDD2213 | [6] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0625 | F8 | Ramos | C217(1.79); C378(1.16); C465(1.01) | LDD2187 | [7] |
LDCM0572 | Fragment10 | Ramos | C217(0.93); C378(1.17); C465(1.06) | LDD2189 | [7] |
LDCM0573 | Fragment11 | Ramos | C217(1.35); C378(0.28); C465(0.32) | LDD2190 | [7] |
LDCM0574 | Fragment12 | Ramos | C217(1.93); C378(1.93); C465(1.99) | LDD2191 | [7] |
LDCM0575 | Fragment13 | Ramos | C217(0.95); C378(1.19); C465(0.88) | LDD2192 | [7] |
LDCM0576 | Fragment14 | Ramos | C217(1.46); C378(1.40); C465(1.90) | LDD2193 | [7] |
LDCM0579 | Fragment20 | Ramos | C217(1.23); C378(1.74); C465(1.83) | LDD2194 | [7] |
LDCM0580 | Fragment21 | Ramos | C217(0.88); C378(1.25); C465(0.74) | LDD2195 | [7] |
LDCM0582 | Fragment23 | Ramos | C217(0.72); C378(0.92); C465(2.17) | LDD2196 | [7] |
LDCM0578 | Fragment27 | Ramos | C217(0.93); C378(0.92); C465(0.75) | LDD2197 | [7] |
LDCM0586 | Fragment28 | Ramos | C217(0.74); C378(0.90); C465(0.80) | LDD2198 | [7] |
LDCM0588 | Fragment30 | Ramos | C217(1.09); C378(1.40); C465(1.03) | LDD2199 | [7] |
LDCM0589 | Fragment31 | Ramos | C217(0.98); C378(1.05); C465(1.19) | LDD2200 | [7] |
LDCM0590 | Fragment32 | Ramos | C217(0.97); C378(1.35); C465(1.53) | LDD2201 | [7] |
LDCM0468 | Fragment33 | Ramos | C217(0.87); C378(1.08); C465(1.27) | LDD2202 | [7] |
LDCM0596 | Fragment38 | Ramos | C217(1.24); C378(0.90); C465(0.90) | LDD2203 | [7] |
LDCM0566 | Fragment4 | Ramos | C217(3.41); C378(1.59); C465(1.65) | LDD2184 | [7] |
LDCM0610 | Fragment52 | Ramos | C217(1.08); C378(1.23); C465(1.38) | LDD2204 | [7] |
LDCM0614 | Fragment56 | Ramos | C217(1.29); C378(1.25); C465(0.73) | LDD2205 | [7] |
LDCM0569 | Fragment7 | Ramos | C217(0.98); C378(1.57); C465(1.89) | LDD2186 | [7] |
LDCM0571 | Fragment9 | Ramos | C217(1.38); C378(1.87); C465(1.44) | LDD2188 | [7] |
LDCM0022 | KB02 | Ramos | C217(1.32); C378(1.66); C465(2.13) | LDD2182 | [7] |
LDCM0023 | KB03 | Jurkat | C378(5.19); C465(9.86); C465(24.45) | LDD0209 | [2] |
LDCM0024 | KB05 | MOLM-13 | C408(1.85); C217(1.27); C495(1.35) | LDD3333 | [8] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Enzyme
Transporter and channel
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Heat shock protein HSP 90-beta (HSP90AB1) | Heat shock protein 90 family | P08238 |
Transcription factor
Immunoglobulin
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
T-cell surface glycoprotein CD4 (CD4) | . | P01730 |
Other
The Drug(s) Related To This Target
Approved
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Vx-680 | Small molecular drug | D02XNW |
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Isis-crp | Antisense drug | D06CIJ | |||
Jnj-26483327 | . | D0U3XL |
Investigative
References